| "A primary focus of this research is directed towards
understanding the role of glycoconjugates in normal biological function and
disease, an area that has brought us international recognition." |
| |
Dr. Jim Richards,
Research Director, Immunobiology
Program |
The Immunobiology Program carries out
molecular-level research of strategic importance on infectious diseases and
cancer. Genomics and proteomics research is playing a central role in Program
activities and is leading to new targets for therapeutic intervention and
vaccine design. The Immunobiology Program brings together a multidisciplinary
team of about 70 scientists and technicians with expertise ranging from
biophysics to models of disease pathogenesis. The program structure comprises
six distinct groups: Immunomodulation,
Infections and Immunity,Antibody Engineering,
Molecular Pathogenesis. |
